Home » Psychology news » World’s first congenital pituitary hypoplasia model developed using patient-derived iPS cells
World’s first congenital pituitary hypoplasia model developed using patient-derived iPS cells
February 14, 2020 by NewsBot
Researchers have developed the world's first congenital pituitary hypoplasia (CPH) model using patient-derived iPS cells. The research group succeeded in using the model to illuminate the mechanisms underlying CPH. The team has been attempting to apply this model to other pituitary diseases and drug discovery.
